Skip to content

Deep learning-based cfDNA multiomics liquid biopsy technology to explore the scientific research of colorectal cancer early screening model

Deep learning-based cfDNA multiomics liquid biopsy technology to explore the scientific research of colorectal cancer early screening model

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073989
Enrollment
Unknown
Registered
2023-07-26
Start date
2023-07-26
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Gold Standard:Pathology confirmed colorectal cancer or adenoma
Index test:Deep learning-based cfDNA multiomics liquid biopsy technology

Sponsors

Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (a) =18 years of age. (b) The subject's plasma for that period may be obtained. (c) Voluntarily participate in the study and sign the informed consent. (d) meet one of the following criteria: ? Patients diagnosed with invasive colorectal cancer for the first time or with colorectal carcinoma in situ for the first time. ? The pathological diagnosis was colorectal polyp.

Exclusion criteria

Exclusion criteria: (a) is pregnant or breastfeeding; . (b) The patient had another type of malignancy with a definite pathological diagnosis within 5 years prior to enrollment. (c) The presence of other malignant tumors suspected by imaging (B-ultrasound, CT, etc.) within the last 1 year of enrollment. (d) have received any blood product input therapy in the last 30 days. (e) Vulnerable groups, including persons with mental illness, persons with cognitive impairment, critically ill patients, minors, pregnant women, illiterates, etc.

Design outcomes

Primary

MeasureTime frame
To evaluate the sensitivity and specificity of this data model in screening colorectal cancer;

Secondary

MeasureTime frame
TeFei? score;

Countries

China

Contacts

Public ContactXu Dengyong

Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine

3413005@zju.edu.cn+86 187 6814 0676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026